Unlocking The Potential of Ubiquitin Enzyme E2 Q Family Like 1

Target Name: UBE2QL1

NCBI ID: G134111

UBE2QL1

Other Name(s): ubiquitin conjugating enzyme E2 Q family like 1 | Ubiquitin-conjugating enzyme E2Q-like protein 1 | U2QL1_HUMAN | Ubiquitin conjugating enzyme E2 Q family like 1 | ubiquitin-conjugating enzyme E2Q family-like 1 | ubiquitin-conjugating enzyme E2Q-like protein 1 | E2Q-like ubiquitin-conjugating enzyme 1

Unlocking The Potential of Ubiquitin Enzyme E2 Q Family Like 1

Ubiquitin conjugating enzyme E2 Q family like 1 (UBE2QL1) is a protein that plays a crucial role in cellular signaling pathways. It is a member of the Q family of proteins that belong to the ubiquitin system, which is a network of proteins that regulate protein-protein interactions in the cell. UBE2QL1 is a 21-kDa protein that is expressed in various cell types, including human tissues and organs.

The ubiquitin system is a complex protein-protein interaction network that plays a central role in protein regulation and degradation. It is composed of five classes of proteins: E1, E2, E3, E4, and E5. Each class of protein has a specific function in the system. UBE2QL1 is a member of the E2 class of proteins, which includes enzymes that convert ubiquitin monomers to polyammonium salt forms.

UBE2QL1 is a critical enzyme in the regulation of protein-protein interactions. It catalyzes the conversion of ubiquitin monomers to polyammonium salt forms, which are then added to target proteins to form a covalent complex. This process is called ubiquitination, and it is a key step in the regulation of protein interactions. UBE2QL1 is highly specific for its target proteins, and it can efficiently convert ubiquitin monomers from various sources, including cellular stress, chemotoxins, and metabolic stress.

The Ubiquitin System in Cellular Signaling

Ubiquitin is a small protein that is composed of 76 amino acid residues. It has a monoclonal sequence and a molecular weight of 21 kDa. It is a highly conserved protein that is found in various cell types, including human cells.

The ubiquitin system plays a crucial role in cellular signaling pathways. It is involved in the regulation of protein-protein interactions, DNA damage repair, and cell growth. UBE2QL1 is a key enzyme in the ubiquitin system that is involved in the regulation of protein-protein interactions.

UBE2QL1 is a critical enzyme in the regulation of protein-protein interactions. It is involved in the formation of protein-protein covalent bonds and in the regulation of protein stability. UBE2QL1 can efficiently convert ubiquitin monomers from various sources, including cellular stress, chemotoxins, and metabolic stress.

Drug Targets and Biomarkers

Drug targets for UBE2QL1 are currently being studied for its potential in treating various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. UBE2QL1 has been shown to be involved in the regulation of cellular stress, chemotoxins, and DNA damage repair, making it an attractive drug target for diseases that are characterized by these processes.

One potential drug target for UBE2QL1 is cancer. UBE2QL1 has been shown to be involved in the regulation of DNA damage repair in various cancer cells. In fact, UBE2QL1 has been shown to play a role in the regulation of DNA damage repair in human breast cancer cells, where it has been shown to enhance the sensitivity of these cells to chemotherapy drugs.

Another potential drug target for UBE2QL1 is neurodegenerative diseases. UBE2QL1 has been shown to be involved in the regulation of protein-protein interactions in various neurodegenerative diseases. For example, UBE2QL1 has been shown to play a role in the regulation of protein-protein interactions in the development of neurofibrillary tangles in Alzheimer's disease.

In addition to these potential drug targets, UBE2QL1 has also been shown to be

Protein Name: Ubiquitin Conjugating Enzyme E2 Q Family Like 1

Functions: Probable E2 ubiquitin-protein ligase that catalyzes the covalent attachment of ubiquitin to target proteins. May facilitate the monoubiquitination and degradation of MTOR and CCNE1 through interaction with FBXW7

The "UBE2QL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UBE2QL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets